99 related articles for article (PubMed ID: 24114913)
1. Multicenter method evaluation of the ARK™ Methotrexate Immunoassay.
Godefroid MJ; von Meyer A; Parsch H; Streichert T; Verstraete AG; Stove V
Clin Chem Lab Med; 2014 Feb; 52(2):e13-6. PubMed ID: 24114913
[No Abstract] [Full Text] [Related]
2. Evaluation of a Methotrexate Chemiluminescent Microparticle Immunoassay: Comparison to Fluorescence Polarization Immunoassay and Liquid Chromatography-Tandem Mass Spectrometry.
Bouquié R; Grégoire M; Hernando H; Azoulay C; Dailly E; Monteil-Ganière C; Pineau A; Deslandes G; Jolliet P
Am J Clin Pathol; 2016 Jul; 146(1):119-24. PubMed ID: 27357291
[TBL] [Abstract][Full Text] [Related]
3. External quality assessment of Syva Emit and Abbott TDx II assays for methotrexate in serum.
Wilson JF; Tsanaclis LM; Barnett K
Ther Drug Monit; 1996 Dec; 18(6):721-3. PubMed ID: 8946672
[TBL] [Abstract][Full Text] [Related]
4. Reduced elimination of Methotrexate in an adult with trisomy 21 and acute lymphoblastic leukaemia.
Thachil J
Leuk Res; 2007 Oct; 31(10):1452-3. PubMed ID: 17178159
[No Abstract] [Full Text] [Related]
5. Evaluation of time to clearance of high-dose methotrexate using the ARK immunoassay in pediatric hematology/oncology patients: A single-center experience.
Kowalski KE; Higgins TA
Pediatr Blood Cancer; 2021 Mar; 68(3):e28788. PubMed ID: 33164288
[TBL] [Abstract][Full Text] [Related]
6. Successful rescue by oral cholestyramine of a patient with methotrexate nephrotoxicity: nonrenal excretion of serum methotrexate.
Shinozaki T; Watanabe H; Tomidokoro R; Yamamoto K; Horiuchi R; Takagishi K
Med Pediatr Oncol; 2000 Mar; 34(3):226-8. PubMed ID: 10696135
[No Abstract] [Full Text] [Related]
7. Therapeutic drug monitoring of methotrexate on the pediatric oncology ward: can blood sampling from central venous accesses substitute for capillary finger punctures?
Ritzmo C; Albertioni F; Cosic K; Söderhäll S; Eksborg S
Ther Drug Monit; 2007 Aug; 29(4):447-51. PubMed ID: 17667799
[TBL] [Abstract][Full Text] [Related]
8. Will nanobiosensors change therapeutic drug monitoring? The case of methotrexate.
Masson JF; Pelletier JN
Nanomedicine (Lond); 2015 Mar; 10(4):521-4. PubMed ID: 25723087
[No Abstract] [Full Text] [Related]
9. Methotrexate elimination in a patient with an orthotopic neobladder with and without a urethral catheter.
Wire PD; Dupuis RE; Mohler JL; Bernard SA; Lindley CM
Pharmacotherapy; 1996; 16(5):961-4. PubMed ID: 8888094
[TBL] [Abstract][Full Text] [Related]
10. Commentary.
Milone MC
Clin Chem; 2010 Dec; 56(12):1795-6. PubMed ID: 21119036
[No Abstract] [Full Text] [Related]
11. Commentary.
Fox E; Balis FM
Clin Chem; 2010 Dec; 56(12):1795. PubMed ID: 21119037
[No Abstract] [Full Text] [Related]
12. Monitoring methotrexate in clinical samples from cancer patients during chemotherapy with a LSPR-based competitive sensor.
Zhao SS; Bichelberger MA; Colin DY; Robitaille R; Pelletier JN; Masson JF
Analyst; 2012 Oct; 137(20):4742-50. PubMed ID: 22943049
[TBL] [Abstract][Full Text] [Related]
13. [Adaptation of methotrexate determination in serum with Unicel DxC600(®)].
Saada S; Olichet B; Bronzini T; Berrafato S; Lokiec F; Rezaï K; Troalen F; Sastre X
Ann Biol Clin (Paris); 2012; 70(3):277-86. PubMed ID: 22565175
[TBL] [Abstract][Full Text] [Related]
14. Effective removal of methotrexate by high-flux hemodialysis.
Saland JM; Leavey PJ; Bash RO; Hansch E; Arbus GS; Quigley R
Pediatr Nephrol; 2002 Oct; 17(10):825-9. PubMed ID: 12376811
[TBL] [Abstract][Full Text] [Related]
15. The influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination.
Klapkova E; Kukacka J; Kotaska K; Suchanska I; Urinovska R; Prusa R
Clin Lab; 2011; 57(7-8):599-606. PubMed ID: 21888024
[TBL] [Abstract][Full Text] [Related]
16. [Methotrexate].
Yamada M
Nihon Rinsho; 1999 Sep; 57 Suppl():421-4. PubMed ID: 10543143
[No Abstract] [Full Text] [Related]
17. [Methotrexate (MTX)].
Yamada M
Nihon Rinsho; 1995 Feb; 53 Su Pt 1():1053-5. PubMed ID: 8753620
[No Abstract] [Full Text] [Related]
18. Molecularly imprinted solid-phase extraction combined with electrochemical oxidation fluorimetry for the determination of methotrexate in human serum and urine.
Chen S; Zhang Z
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jun; 70(1):36-41. PubMed ID: 17904892
[TBL] [Abstract][Full Text] [Related]
19. Determination of methotrexate in serum: the aca MTHO immunoassay and HPLC compared.
Martz W; Oellerich M; Schumann G
J Clin Chem Clin Biochem; 1990 Dec; 28(12):951-3. PubMed ID: 2081968
[TBL] [Abstract][Full Text] [Related]
20. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G
Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
